デフォルト表紙
市場調査レポート
商品コード
1753974

スマートシリンジ市場レポート:製品別、年齢層別、アプリケーション別、エンドユーザー別、地域別、2025年~2033年

Smart Syringe Market Report by Product, Age Group, Application, End User (Hospitals and HMOs, Diabetic Patients, Family Practices, Psychiatrics, and Others), and Region 2025-2033


出版日
発行
IMARC
ページ情報
英文 136 Pages
納期
2~3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=145.58円
スマートシリンジ市場レポート:製品別、年齢層別、アプリケーション別、エンドユーザー別、地域別、2025年~2033年
出版日: 2025年06月02日
発行: IMARC
ページ情報: 英文 136 Pages
納期: 2~3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

スマートシリンジの世界市場規模は2024年に102億米ドルに達しました。今後、IMARC Groupは、市場は2033年までに181億米ドルに達し、2025年から2033年にかけて6.30%の成長率(CAGR)を示すと予測しています。医療安全に対する意識の高まり、針刺し傷害を防止する必要性の高まり、安全な注射法に関する規制の高まり、医療技術の進歩、ワクチン接種プログラムの増加、HIVや肝炎などの感染症の蔓延を抑えることへの世界の注力などが、市場成長を後押しする主な要因の一部です。

スマートシリンジは、再使用を防止し、安全でない注射を規制するための安全機構を備えた医療機器です。プリセットパラメーター、使用範囲、使用状況の追跡機能を備えた読み書き可能なチップが組み込まれています。一般的に、自動無効化(AD)、パッシブセーフティ、アクティブセーフティシリンジのバリエーションがあります。ヒト免疫不全ウイルス(HIV)、A型肝炎、B型肝炎、糖尿病などの重篤な疾患や症状を持つ患者の治療に役立ちます。ワクチン接種、ドラッグデリバリー、血液検体採取などに使用されます。その結果、世界中の病院、診療所、診断所、予防接種センターで利用されています。

スマートシリンジ市場動向:

感染予防と医療安全の重視の高まり

医療プロバイダーは、病気の感染を防ぐために安全な注射を行うことを優先しているため、感染対策への注目はスマートシリンジ市場の主要促進要因となっています。従来の注射器は、地域によっては資源の制約から再利用されることが多く、HIVや肝炎などの感染症を広げるリスクを大幅に高めています。自動無効化機能と安全ロック機能を備えたスマートシリンジは、再使用を排除するように設計されており、こうした懸念に効果的に対処しています。現在、多くの国で医療における安全注射器の使用が義務付けられており、これは世界の感染管理を提唱する保健団体の勧告に沿ったものです。医療関連感染に対する認識と規制の高まりは、医療施設や組織にスマートシリンジの採用を促しています。スマートシリンジの市場分析によると、このシフトは病院、診療所、ワクチン接種プログラムにおいて顕著であり、感染予防対策は医療従事者と患者の両方を潜在的な感染因子への暴露から守るために不可欠です。

医療技術の進歩と使い捨て医療機器

医療技術における継続的な技術革新は、スマートシリンジ市場の成長を大きく後押ししており、特に医療システムでは使い捨ての安全設計機器が好まれるようになっています。これに伴い、スマートシリンジへの研究開発(R&D)投資は、針刺し傷害を最小限に抑え、再使用を防止するように設計された、引き込み可能な針や自動無効化機構などの高度な機能の開発につながり、スマートシリンジ市場全体のシェアをさらに拡大すると予想されます。これらの技術革新は、注射器の安全性と機能性を向上させるだけでなく、より入手しやすく手頃な価格での提供を可能にしています。これに加えて、世界中の規制機関がより厳格な安全ガイドラインを設定し、メーカーにさらなる技術革新を促しています。このような技術的進化は、交差汚染のリスクを軽減するのに役立つ使い捨て医療機器への医療業界のシフトと一致しています。技術の向上に伴い、スマートシリンジは現代の医療施設に不可欠なものとなりつつあり、特に病院や診療所のようなリスクの高い環境において、より安全な診療をサポートし、感染の可能性を低減しています。

予防接種プログラムの拡大と世界のワクチン接種への取り組み

世界の予防接種の取り組みがスマートシリンジの需要を加速しています。特に、最近の世界の健康課題を考慮すると、大規模な予防接種プログラムがますます重要になってきており、これが世界中でスマートシリンジ市場の成長を後押ししています。WHOやユニセフなどの組織は、注射針の再使用を防ぎ交差汚染のリスクを低減するため、こうしたキャンペーンで安全設計注射器を使用することの重要性を強調しています。スマートシリンジ、特に自動ディスエイブルタイプのシリンジは、使い捨てが可能であるため、特に医療のインフラが整っていない地域での集団予防接種に理想的です。これらのプログラムは、予防可能な疾病の蔓延を抑制する上で安全な注射の実践が重要であることを強調するものであり、市場成長の原動力となることが期待されます。スマートシリンジの市場予測によると、予防接種範囲の拡大と安全な投与の確保に取り組む国が増えるにつれて、スマート注射器の採用が増加し、安全プロトコルの遵守を確保しながらワクチンで予防可能な病気の負担を軽減するのに役立つと予想されています。

本レポートで扱う主な質問

  • 2024年の世界のスマートシリンジ市場規模は?
  • 2025-2033年におけるスマートシリンジの世界市場予測成長率は?
  • スマートシリンジの世界市場を牽引する主要因は?
  • スマートシリンジの世界市場におけるCOVID-19の影響は?
  • スマートシリンジの世界市場における製品別の区分は?
  • スマートシリンジの世界市場における年齢層別の区分は?
  • スマートシリンジの世界市場におけるアプリケーション別の区分は?
  • スマートシリンジの世界市場におけるエンドユーザー別の市場内訳は?
  • スマートシリンジの世界市場における主要地域は?
  • スマートシリンジの世界市場における主要プレイヤー/企業は?

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査の目的
  • ステークホルダー
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要業界動向

第5章 世界のスマートシリンジ市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場予測

第6章 市場内訳:製品別

  • 自動無効化シリンジ
  • アクティブセーフティシリンジ
  • パッシブセーフティシリンジ

第7章 市場内訳:年齢層別

  • 小児
  • 成人

第8章 市場内訳:アプリケーション別

  • ドラッグデリバリー
  • ワクチン接種
  • 血液検体採取

第9章 市場内訳:エンドユーザー別

  • 病院・HMO
  • 糖尿病患者
  • 家庭医療(医師)
  • 精神医療
  • その他

第10章 市場内訳:地域別

  • 北米
    • 米国
    • カナダ
  • アジア太平洋地域
    • 中国
    • 日本
    • インド
    • 韓国
    • オーストラリア
    • インドネシア
    • その他
  • 欧州
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • スペイン
    • ロシア
    • その他
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • その他
  • 中東・アフリカ
    • 市場内訳:国別

第11章 SWOT分析

  • 概要
  • 強み
  • 弱み
  • 機会
  • 脅威

第12章 バリューチェーン分析

第13章 ポーターのファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の程度
  • 新規参入業者の脅威
  • 代替品の脅威

第14章 価格分析

第15章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • AdvaCare Pharma
    • B. Braun Melsungen AG
    • Becton, Dickinson and Company
    • Gerresheimer AG
    • Merit Medical Systems Inc.
    • Nipro Corporation
    • Numedico Technologies Pty Ltd.
    • Retractable Technologies Inc.
    • Terumo Corporation
図表

List of Figures

  • Figure 1: Global: Smart Syringe Market: Major Drivers and Challenges
  • Figure 2: Global: Smart Syringe Market: Sales Value (in Billion USD), 2019-2024
  • Figure 3: Global: Smart Syringe Market Forecast: Sales Value (in Billion USD), 2025-2033
  • Figure 4: Global: Smart Syringe Market: Breakup by Product (in %), 2024
  • Figure 5: Global: Smart Syringe Market: Breakup by Age Group (in %), 2024
  • Figure 6: Global: Smart Syringe Market: Breakup by Application (in %), 2024
  • Figure 7: Global: Smart Syringe Market: Breakup by End User (in %), 2024
  • Figure 8: Global: Smart Syringe Market: Breakup by Region (in %), 2024
  • Figure 9: Global: Smart Syringe (Auto-disable Syringes) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 10: Global: Smart Syringe (Auto-disable Syringes) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 11: Global: Smart Syringe (Active Safety Syringes) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 12: Global: Smart Syringe (Active Safety Syringes) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 13: Global: Smart Syringe (Passive Safety Syringes) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 14: Global: Smart Syringe (Passive Safety Syringes) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 15: Global: Smart Syringe (Pediatrics) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 16: Global: Smart Syringe (Pediatrics) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 17: Global: Smart Syringe (Adults) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 18: Global: Smart Syringe (Adults) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 19: Global: Smart Syringe (Drug Delivery) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 20: Global: Smart Syringe (Drug Delivery) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 21: Global: Smart Syringe (Vaccination) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 22: Global: Smart Syringe (Vaccination) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 23: Global: Smart Syringe (Blood Specimen Collection) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 24: Global: Smart Syringe (Blood Specimen Collection) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 25: Global: Smart Syringe (Hospitals and HMOs) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 26: Global: Smart Syringe (Hospitals and HMOs) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 27: Global: Smart Syringe (Diabetic Patients) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 28: Global: Smart Syringe (Diabetic Patients) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 29: Global: Smart Syringe (Family Practices (Physicians)) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 30: Global: Smart Syringe (Family Practices (Physicians)) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 31: Global: Smart Syringe (Psychiatrics) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 32: Global: Smart Syringe (Psychiatrics) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 33: Global: Smart Syringe (Other End Users) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 34: Global: Smart Syringe (Other End Users) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 35: North America: Smart Syringe Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 36: North America: Smart Syringe Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 37: United States: Smart Syringe Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 38: United States: Smart Syringe Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 39: Canada: Smart Syringe Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 40: Canada: Smart Syringe Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 41: Asia-Pacific: Smart Syringe Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 42: Asia-Pacific: Smart Syringe Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 43: China: Smart Syringe Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 44: China: Smart Syringe Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 45: Japan: Smart Syringe Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 46: Japan: Smart Syringe Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 47: India: Smart Syringe Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 48: India: Smart Syringe Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 49: South Korea: Smart Syringe Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 50: South Korea: Smart Syringe Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 51: Australia: Smart Syringe Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 52: Australia: Smart Syringe Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 53: Indonesia: Smart Syringe Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 54: Indonesia: Smart Syringe Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 55: Others: Smart Syringe Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 56: Others: Smart Syringe Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 57: Europe: Smart Syringe Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 58: Europe: Smart Syringe Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 59: Germany: Smart Syringe Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 60: Germany: Smart Syringe Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 61: France: Smart Syringe Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 62: France: Smart Syringe Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 63: United Kingdom: Smart Syringe Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 64: United Kingdom: Smart Syringe Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 65: Italy: Smart Syringe Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 66: Italy: Smart Syringe Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 67: Spain: Smart Syringe Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 68: Spain: Smart Syringe Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 69: Russia: Smart Syringe Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 70: Russia: Smart Syringe Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 71: Others: Smart Syringe Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 72: Others: Smart Syringe Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 73: Latin America: Smart Syringe Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 74: Latin America: Smart Syringe Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 75: Brazil: Smart Syringe Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 76: Brazil: Smart Syringe Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 77: Mexico: Smart Syringe Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 78: Mexico: Smart Syringe Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 79: Others: Smart Syringe Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 80: Others: Smart Syringe Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 81: Middle East and Africa: Smart Syringe Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 82: Middle East and Africa: Smart Syringe Market: Breakup by Country (in %), 2024
  • Figure 83: Middle East and Africa: Smart Syringe Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 84: Global: Smart Syringe Industry: SWOT Analysis
  • Figure 85: Global: Smart Syringe Industry: Value Chain Analysis
  • Figure 86: Global: Smart Syringe Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Smart Syringe Market: Key Industry Highlights, 2024 and 2033
  • Table 2: Global: Smart Syringe Market Forecast: Breakup by Product (in Million USD), 2025-2033
  • Table 3: Global: Smart Syringe Market Forecast: Breakup by Age Group (in Million USD), 2025-2033
  • Table 4: Global: Smart Syringe Market Forecast: Breakup by Application (in Million USD), 2025-2033
  • Table 5: Global: Smart Syringe Market Forecast: Breakup by End User (in Million USD), 2025-2033
  • Table 6: Global: Smart Syringe Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 7: Global: Smart Syringe Market: Competitive Structure
  • Table 8: Global: Smart Syringe Market: Key Players
目次
Product Code: SR112025A6399

The global smart syringe market size reached USD 10.2 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 18.1 Billion by 2033, exhibiting a growth rate (CAGR) of 6.30% during 2025-2033. The increasing awareness of healthcare safety, the rising need to prevent needle-stick injuries, growing regulations on safe injection practices, advancements in healthcare technologies, rising vaccination programs, and the global focus on reducing the spread of infections, such as HIV and hepatitis are some of the major factors propelling the market growth.

A smart syringe is a medical device engineered with safety mechanisms to prevent reuse and regulate unsafe injection practices. It is incorporated with a read and write chip with preset parameters, ranges, and usage tracking. It is commonly available in variants of auto-disable (AD), passive safety, and active safety syringes. It aids in treating patients with critical disorders and conditions, such as human immunodeficiency virus (HIV), hepatitis A, hepatitis B, and diabetes. It is used for vaccination, drug delivery, and blood specimen collection. As a result, it is utilized in hospitals, clinics, diagnostics, and vaccination centers across the globe.

Smart Syringe Market Trends:

Growing Emphasis on Infection Prevention and Healthcare Safety

The focus on infection control is a major driver in the smart syringe market as healthcare providers prioritize safe injection practices to prevent disease transmission. Traditional syringes, often reused in some regions due to resource constraints, significantly raise the risk of spreading infections like HIV and hepatitis. Smart syringes, equipped with auto-disable and safety lock features, are designed to eliminate reuse, addressing these concerns effectively. Many countries now mandate the use of safety syringes in healthcare, aligning with recommendations from health organizations that advocate for global infection control. The increasing awareness and regulations related to healthcare-associated infections encourage healthcare facilities and organizations to adopt smart syringes. According to the smart syringe market analysis, this shift is evident in hospitals, clinics, and vaccination programs, where infection prevention measures are critical to protecting both healthcare workers and patients from potential exposure to infectious agents.

Advancements in Medical Technology and Disposable Healthcare Devices

Ongoing innovations in medical technology significantly drive the smart syringe market growth, especially as healthcare systems increasingly prefer disposable, safety-engineered devices. In line with this, research and development (R&D) investments in smart syringes have led to the development of advanced features such as retractable needles and auto-disable mechanisms, designed to minimize needle-stick injuries and prevent reuse, which is further expected to increase the overall smart syringe market share. These innovations are not only enhancing the safety and functionality of syringes but are also making them more accessible and affordable. In addition to this, regulatory bodies worldwide are setting stricter safety guidelines, prompting manufacturers to innovate further. This technological evolution aligns with the healthcare industry's shift towards single-use medical devices, which help mitigate cross-contamination risks. As technology improves, smart syringes are becoming integral to modern healthcare facilities, supporting safer practices and reducing the chances of infection, particularly in high-risk environments such as hospitals and clinics.

Expansion of Immunization Programs and Global Vaccination Efforts

Worldwide immunization initiatives are accelerating the demand for smart syringes, particularly with large-scale vaccination programs becoming increasingly critical considering recent global health challenges, which are boosting the smart syringe market growth across the globe. Organizations such as WHO and UNICEF have underscored the importance of using safety-engineered syringes in these campaigns to prevent needle reuse and reduce the risk of cross-contamination. Smart syringes, particularly auto-disable types, ensure single-use applications, making them ideal for mass immunization drives, especially in regions with limited healthcare infrastructure. These programs underscore the importance of safe injection practices in controlling the spread of preventable diseases which is expected to drive the market growth. According to the smart syringe market forecast, as more countries commit to expanding immunization coverage and ensuring safe administration, the adoption of smart syringes is expected to rise, helping reduce the burden of vaccine-preventable diseases while ensuring adherence to safety protocols.

Key Market Segmentation:

Breakup by Product:

  • Auto-disable Syringes
  • Active Safety Syringes
  • Passive Safety Syringes

Breakup by Age Group:

  • Pediatrics
  • Adults

Breakup by Application:

  • Drug Delivery
  • Vaccination
  • Blood Specimen Collection

Breakup by End User:

  • Hospitals and HMOs
  • Diabetic Patients
  • Family Practices (Physicians)
  • Psychiatrics
  • Others

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

Competitive Landscape:

The report has also provided a comprehensive analysis of the competitive landscape in the global smart syringe market. Detailed profiles of all major companies have also been provided. Some of the companies covered include:

  • AdvaCare Pharma
  • B. Braun Melsungen AG
  • Becton, Dickinson and Company
  • Gerresheimer AG
  • Merit Medical Systems Inc.
  • Nipro Corporation
  • Numedico Technologies Pty Ltd.
  • Retractable Technologies Inc.
  • Terumo Corporation

Key Questions Answered in This Report

  • 1.What was the size of the global smart syringe market in 2024?
  • 2.What is the expected growth rate of the global smart syringe market during 2025-2033?
  • 3.What are the key factors driving the global smart syringe market?
  • 4.What has been the impact of COVID-19 on the global smart syringe market?
  • 5.What is the breakup of the global smart syringe market based on the product?
  • 6.What is the breakup of the global smart syringe market based on age group?
  • 7.What is the breakup of the global smart syringe market based on the application?
  • 8.What is the breakup of the global smart syringe market based on the end user?
  • 9.What are the key regions in the global smart syringe market?
  • 10.Who are the key players/companies in the global smart syringe market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Smart Syringe Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Auto-disable Syringes
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Active Safety Syringes
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Passive Safety Syringes
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast

7 Market Breakup by Age Group

  • 7.1 Pediatrics
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Adults
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast

8 Market Breakup by Application

  • 8.1 Drug Delivery
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Vaccination
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Blood Specimen Collection
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by End User

  • 9.1 Hospitals and HMOs
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Diabetic Patients
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Family Practices (Physicians)
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4 Psychiatrics
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast
  • 9.5 Others
    • 9.5.1 Market Trends
    • 9.5.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia-Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 AdvaCare Pharma
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
    • 15.3.2 B. Braun Melsungen AG
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
      • 15.3.2.3 SWOT Analysis
    • 15.3.3 Becton, Dickinson and Company
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
      • 15.3.3.3 Financials
      • 15.3.3.4 SWOT Analysis
    • 15.3.4 Gerresheimer AG
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
      • 15.3.4.3 Financials
    • 15.3.5 Merit Medical Systems Inc.
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
      • 15.3.5.3 Financials
      • 15.3.5.4 SWOT Analysis
    • 15.3.6 Nipro Corporation
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
      • 15.3.6.3 Financials
      • 15.3.6.4 SWOT Analysis
    • 15.3.7 Numedico Technologies Pty Ltd.
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
    • 15.3.8 Retractable Technologies Inc.
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
      • 15.3.8.3 Financials
    • 15.3.9 Terumo Corporation
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
      • 15.3.9.3 Financials
      • 15.3.9.4 SWOT Analysis